Back
Artelo Biosciences 10K Form
Sell
32
ARTL
Artelo Biosciences
Last Price:
1.38
Seasonality Move:
-11.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARTL News And Ratings
See the #1 stock for the next 7 days that we like better than ARTL
ARTL Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-2.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.69 |
| Price / Book: | 0.37 |
Profitability
| EPS (TTM): | -3.14000 |
|---|---|
| Net Income (TTM): | $-9.29M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Artelo Biosciences Earnings Forecast
Key Artelo Biosciences Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 10 years have been positive in 4 years.
Artelo Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ARTL |
| Website: | artelobio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ARTL Technical Analysis vs Fundamental Analysis
Sell
32
Artelo Biosciences (ARTL)
is a Sell
Is Artelo Biosciences a Buy or a Sell?
-
Artelo Biosciences stock is rated a Sell
The current Artelo Biosciences [ARTL] share price is $1.35. The Score for ARTL is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.